An Open-Label, Fixed-Sequence Study to Assess Effects of Steady-State Rifampin on the Single-Dose Pharmacokinetics of Canagliflozin in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 03 May 2013
At a glance
- Drugs Canagliflozin; Rifampicin
- Indications Bacterial infections; Hyperglycaemia
- Focus Pharmacokinetics
- 20 Oct 2011 Actual end date (August 2011) added as reported by ClinicalTrials.gov.
- 20 Oct 2011 Actual initiation date (July 2011) added as reported by ClinicalTrials.gov.
- 20 Oct 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.